학술논문
A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202)
Document Type
Article
Author
Source
In ESMO Open August 2022 7(4)
Subject
Language
ISSN
2059-7029